Columnistas Expertos

Expertos Invitados

Anders Asberg
Columnista Experta de SIIC

Professor, Department of Pharmaceutical Bioscience, School of Pharmacy, University of Oslo, Oslo, Noruega

Artículos publicados (selección):

INTERACCIONES BILATERALES ENTRE CICLOSPORINA A Y TRATAMIENTOS HIPOLIPEMIANTES
Columnista Experta de SIIC Anders Asberg en colaboración con

Fecha de aprobación: 13 de julio, 2005
Primera edición en siicsalud: 20 de febrero, 2006
Sección Artículos originales, subsección Expertos de Iberoamérica,
página /des/expertocompleto.php/75078
Especialidad principal: Farmacología
Trasplantes

Especialidades relacionadas:

Cardiología,

Diagnóstico por Laboratorio,

Medicina Farmacéutica,

Inmunología,

Medicina Interna,

Hjelmesaet J, Åsberg A, Hartmann A, Jenssen T. New-onset diabetes mellitus after renal transplantation: diagnosis and treatment, Int Diabetes Monitor 5(5):15-21

Lemahieu WPD, Hermann M, Åsberg A, Verbeke K, Holdaas H, Vanrenterghem Y, Maes BD. Combined therapy with atorvastatin and calcineurin inhibitors: No interaction with tacrolimus, Am J Transplant 5:2236-2243, 2005

Hermann M, Åsberg A, Christensen H, Reubsaet JLE, Holdaas H, Hartmann A. Atorvastatin does not affect pharmacokinetics of cyclosporine in renal transplant recipients, Eur J Clin Pharmacol 61:59-62, 2005

Voytovich MH, Simonsen C, Jenssen T, Åsberg A, Midtvedt K, Hjelmesaeth J, Hartmann A. Short term treatment with rosiglitazone improves glucose disposal rate and endothelial function in renal transplant recipients with glucose intolerance, Nephrol Dial Transplant 20:413-418, 2005

Hjelmesaeth J, Åsberg A, Müller F, Jenssen T, Hartmann A. New-onset posttransplantation diabetes mellitus: Insulin resistance or insulinopenia Impact of immunosuppressive drugs, hepatitis C virus and cytomegalovirus infection, Current Diabetes Reviews 1(1):1-10, 2005

Hermann M, Åsberg A, Christensen H, Holdaas H, Hartmann A, Reubsaet JLE. Substantially elevated levels of atorvastatin and metabolites in cyclosporine A treated renal transplant recipients, Clin Pharm Ther 76(76):388-391, 2004

Åsberg, A and Holdaas H Fluvastatin and fluvastatin extended release: a clinical and safety profile, Expert Rev Cardiovasc Ther 2(2):641-652, 2004

Sagedal S, Nordal KP, Hartmann A, Midtvedt K, Foss A, Åsberg A, Degré M, Fauchald P, Rollag H. Pre-emptive therapy of CMVpp65 antigen positive renal transplant recipients with oral ganciclovir: a randomised, comparative study, Nephrol Dial Transplant 18(18):1899-1908, 2003

Anders Asberg

ua40317

Acerca de SIIC

Acceso para suscriptores